H3K27me3缺失提示Tübingen脑膜瘤队列复发风险增加
本研究基于Tübingen脑膜瘤队列(2003-2015年手术,1268例,随访40.3月),评估H3K27me3组化缺失的预后价值。单因素分析中H3K27me3缺失与男性、低龄、颅内位置、进展性肿瘤、次全切除、高WHO分级、高MIB1均为显著不良预后因素;多因素模型中H3K27me3状态等仍显著,辅助放疗为独立良好预后因素。结论支持将H3K27me3组化纳入常规病理评估。
要点
- H3K27me3缺失是脑膜瘤独立不良预后因素,与MIB1联合评估复发风险。
- 多因素模型中H3K27me3状态保持显著,年龄和肿瘤位置不再显著。
- 辅助放疗为独立良好预后因素,H3K27me3组化宜纳入常规病理流程。
核心结论
- H3K27me3缺失联合MIB1标记指数是脑膜瘤独立预后因素,支持H3K27me3免疫组化常规用于病理评估。
研究设计与样本
- 回顾性队列研究,纳入2003年10月至2015年12月在Tübingen大学医院行脑膜瘤切除的患者,共1268例,女男比2.6,平均年龄58.7岁(范围8.3-91.0)。
- 对H3K27me3和增殖标记MIB1行免疫组化染色,采用单因素和多因素Cox回归、Pearson卡方检验及log-rank检验与临床参数关联。
- 163例失访,1103例可进一步分析,平均随访40.3个月(范围1.1-186.3)。
主要发现
- 单因素分析中男性、较年轻年龄、颅内肿瘤位置、进展性肿瘤、次全切除、较高WHO分级、MIB1率升高及H3K27me3缺失均为显著不良预后因素。
- 多因素模型中H3K27me3状态及其他预后因素(除年龄和肿瘤位置外)仍显著。
- 辅助放疗为独立良好预后因素。
临床怎么用
- 对脑膜瘤切除标本常规行H3K27me3免疫组化染色,结合MIB1标记指数评估复发风险。
- H3K27me3缺失提示复发风险增加,可辅助术后随访和辅助治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A loss of the trimethylation of lysine 27 of histone H3 (H3K27me3) in meningioma has been recently suggested as an adjunct to identify subsets of higher risk of recurrence. The aim of the present study was to assess the prognostic value of H3K27 histone trimethylation and its potential clinical utility in the "Tübingen meningioma cohort." METHODS: Patients who underwent meningioma resection between October 2003 and December 2015 at the University Hospital Tübingen were included. Immunohistochemical stainings for H3K27me3 and the proliferation marker MIB1 were assessed and correlated with clinical parameters using univariate and multivariate Cox regressions as well as Pearson's chi-squared and log-rank test. RESULTS: Overall, 1268 meningiomas were analyzed with a female to male ratio of 2.6 and a mean age of 58.7 years (range 8.3-91.0). With 163 cases lost to follow up, 1103 cases were available for further analysis with a mean follow-up of 40.3 months (range 1.1-186.3). Male gender, younger age, intracranial tumor localization, progressive tumor, subtotal resection, higher WHO grade, increased MIB1 rate, and loss of H3K27me3 were significant negative prognostic factors in the univariate analysis. H3K27me3 status and all other prognostic factors, except age and tumor location, remained significant in the multivariate model. Furthermore, adjuvant radiotherapy was an independent positive prognostic factor. CONCLUSIONS: Loss of H3K27me3 combined with MIB1 labeling index are independent prognostic factors in meningioma. These data from the Tübingen meningioma cohort support the clinical utility of H3K27me3 immunohistochemical staining in meningioma and its integration into the routine histopathological workup.
引用
- Behling F, Fodi C, Gepfner-Tuma I, et al. H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort. Neuro Oncol. 2021. PMID: 33367841. doi:10.1093/neuonc/noaa303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。